1. The dietary flavone luteolin epigenetically activates the Nrf2 pathway and blocks cell transformation in human colorectal cancer HCT116 cells
   Qian Zuo et al, 2018, J Cell Biochem CrossRef
2. Natural flavonoids for the prevention of colon cancer: A comprehensive review of preclinical and clinical studies
   Khashayar Afshari et al, 2019, J Cell Physiol CrossRef
3. Cancer Chemoprevention by Dietary Polyphenols, Flavonoids, Terpenoids, and Saponins
   Rahul L. Gajbhiye et al, 2019 CrossRef
4. Luteolin mediated targeting of protein network and microRNAs in different cancers: Focus on JAK-STAT, NOTCH, mTOR and TRAIL-mediated signaling pathways
   Ammad Ahmad Farooqi et al, 2020, Pharmacological Research CrossRef
5. Doxorubicin hydrochloride enhanced antitumour effect of CEA-regulated oncolytic virotherapy in live cancer cells and a mouse model.
   Boduan Xiao et al, 2020, J Cell Mol Med CrossRef
6. Luteolin enhances the antitumor efficacy of oncolytic vaccinia virus that harbors IL‐24 gene in liver cancer cells
   Chunming Wang et al, 2020, J Clin Lab Anal CrossRef
7. Oncolytic Adenovirus CD55-Smad4 Suppresses Cell Proliferation, Metastasis, and Tumor Stemness in Colorectal Cancer by Regulating Wnt/β-Catenin Signaling Pathway
   Boduan Xiao et al, 2020, Biomedicines CrossRef
8. Anticancer activity of the plant flavonoid luteolin against preclinical models of various cancers and insights on different signalling mechanisms modulated
   Shabir Ahmad Ganai et al, 2021, Phytotherapy Research CrossRef
9. Immuno-Oncolytic Viruses: Emerging Options in the Treatment of Colorectal Cancer.
   Sadia Islam Kana et al, 2021, Mol Diagn Ther CrossRef
10. Natural product-based radiopharmaceuticals: Focus on curcumin and its analogs, flavonoids, and marine peptides.
    Hendris Wongso, 2022, J Pharm Anal CrossRef
11. Oncolytic adenovirus carrying SPAG9-shRNA enhanced the efficacy of docetaxel for advanced prostate cancer.
    Meng Lu et al, 2022, Anticancer Drugs CrossRef
12. Oncolytic viruses combined with immune checkpoint therapy for colorectal cancer is a promising treatment option
    Yi Ren et al, 2022, Front. Immunol. CrossRef
13. Luteolin, a Potent Anticancer Compound: From Chemistry to Cellular Interactions and Synergetic Perspectives
    Hardeep Singh Tuli et al, 2022, Cancers CrossRef
14. Phenolic Phytochemicals for Prevention and Treatment of Colorectal Cancer: A Critical Evaluation of In Vivo Studies
    Samhita De et al, 2023, Cancers CrossRef
15. Immunotherapy for colorectal cancer: Rational strategies and novel therapeutic progress
    Farangis Rastin et al, 2024, International Immunopharmacology CrossRef
16. Viral therapy for targeted drug delivery to cancers: Recent advances, clinical and regulatory perspectives
    Kanaka Dhuri et al, 2024, Journal of Drug Delivery Science and Technology CrossRef
17. Investigation of the Antarctic krill tripeptide Phe-Pro-Phe (FPF) for its antioxidant properties and mechanism
    Jingqi Yang et al, 2024, Food Bioscience CrossRef
18. Oncolytic adenovirus encoding LHPP exerts potent antitumor effect in lung cancer
    Yaru Zhao et al, 2024, Sci Rep CrossRef
19. Insight into the structure, function and the tumor suppression effect of gasdermin E
    Yuge Long et al, 2024, Biochemical Pharmacology CrossRef
20. The Role of TRAIL Signaling in Cancer: Searching for New Therapeutic Strategies
    Cheng Luo et al, 2024, Biology CrossRef
21. Advances in the therapeutic study of oncolytic virus in colorectal cancer
    Junjie Chen et al, 2024, Oncol Transl Med CrossRef
22. Unraveling the Anti-Obesity Potential of Luteolin: Mechanistic Insights
    Akhil Sharma et al, 2025, CNF CrossRef